This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.
Jean Robert Delperro, MD
Advertisement
Articles by Jean Robert Delperro, MD
Advertisement
Latest Updated Articles
- Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer
Published: October 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
2
Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer
3
Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma
4
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
5
